Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019: Retrospective Cohort Study
Table 3
Baseline demographic and clinical characteristics associated with viral load suppression among high viral load HIV infected people after enhanced adherence counselling (EAC) session between June 2016 and January 2019, Ethiopia.
Variables
Category
CRR (95% CI)
ARR (95% CI)
value
Sex
Male
1
1
<0.001
Female
1.39 (1.148–1.685)
1.18 (1.017–1.192)
Educational status
Cannot read and write
1
Primary
1.62 (1.171–2.241)
1.38 (1.032–1.841)
0.030
Secondary and above
1.87 (1.378–2.556)
1.65 (1.253–2.164)
<0.001
Residence
Urban
1
1
Rural
0.59 (0.472–0.730)
0.66 (0.544–1.805)
0.301
Duration of ART
≤12 months
1
1
13–35 months
0.77 (0.568–1.053)
0.11 (0.031–0.379)
0.014
36–59 months
0.95 (0.770–1.178)
0.35 (0.130–0.949)
0.023
≥60 months
1.20 (0.932–1.553)
0.40 (0.738–2.217)
0.147
First viral load
1000–5000
1
1
5001–10,000
0.96 (0.811–1.136)
0.93 (0.871–0.989)
0.021
≥10000
0.40 (0.245–0.648)
0.44 (0.277–0.701)
<0.001
Baseline CD4
<200
1
1
201–500
1.04 (0.769–1.418)
0.98 (0.985–1.986)
0.101
≥500
1.37 (1.115–1.680)
0.83 (0.467–1.387)
0.081
Adherence level
Good
1
Fair
0.08 (0.012–0.521)
0.12 (0.092–1.021)
0.215
Poor
0.18 (0.060–0.531)
0.54 (0.240–1.124)
0.131
WHO stage
Stage 1
1
1
1
Stage 2 or 3
1.03 (0.762–1.392)
1.20 (0.845–1.352)
0.801
CRR = crude risk ratio; ARR = adjusted risk ratio; ART = antiretroviral therapy; WHO=World Health Organization. = p < 0.05.